QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

NASDAQ:QDEL • US2197981051

23.58 USD
-0.16 (-0.65%)
At close: Feb 13, 2026
23.85 USD
+0.27 (+1.15%)
After Hours: 2/13/2026, 8:00:00 PM
Fundamental Rating

3

Taking everything into account, QDEL scores 3 out of 10 in our fundamental rating. QDEL was compared to 186 industry peers in the Health Care Equipment & Supplies industry. QDEL may be in some trouble as it scores bad on both profitability and health. QDEL is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year QDEL was profitable.
  • In the past year QDEL had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: QDEL reported negative net income in multiple years.
  • Of the past 5 years QDEL 4 years had a positive operating cash flow.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

  • With a Return On Assets value of -20.78%, QDEL perfoms like the industry average, outperforming 53.23% of the companies in the same industry.
  • QDEL has a Return On Equity (-57.90%) which is in line with its industry peers.
  • QDEL's Return On Invested Capital of 1.74% is fine compared to the rest of the industry. QDEL outperforms 67.74% of its industry peers.
  • QDEL had an Average Return On Invested Capital over the past 3 years of 4.37%. This is below the industry average of 8.83%.
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROIC 1.74%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

  • With a decent Operating Margin value of 3.98%, QDEL is doing good in the industry, outperforming 68.28% of the companies in the same industry.
  • In the last couple of years the Operating Margin of QDEL has declined.
  • QDEL's Gross Margin of 47.15% is in line compared to the rest of the industry. QDEL outperforms 41.94% of its industry peers.
  • In the last couple of years the Gross Margin of QDEL has declined.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 47.15%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QDEL is destroying value.
  • There is no outstanding debt for QDEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.72, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of QDEL (0.72) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.23 is on the high side and indicates that QDEL has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.23, QDEL is not doing good in the industry: 76.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.18
WACC9.67%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.78 indicates that QDEL should not have too much problems paying its short term obligations.
  • The Current ratio of QDEL (1.78) is worse than 66.13% of its industry peers.
  • A Quick Ratio of 0.98 indicates that QDEL may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.98, QDEL is not doing good in the industry: 74.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.98
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 14.59% over the past year.
  • QDEL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -36.12% yearly.
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.23%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.97% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, QDEL will show a small growth in Revenue. The Revenue will grow by 3.50% on average per year.
EPS Next Y19.63%
EPS Next 2Y25.08%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue Next Year2.28%
Revenue Next 2Y3.23%
Revenue Next 3Y3.5%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.12, which indicates a very decent valuation of QDEL.
  • Based on the Price/Earnings ratio, QDEL is valued cheaper than 94.62% of the companies in the same industry.
  • QDEL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.97.
  • With a Price/Forward Earnings ratio of 9.30, the valuation of QDEL can be described as very reasonable.
  • 95.16% of the companies in the same industry are more expensive than QDEL, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of QDEL to the average of the S&P500 Index (27.96), we can say QDEL is valued rather cheaply.
Industry RankSector Rank
PE 11.12
Fwd PE 9.3
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • QDEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QDEL is cheaper than 95.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.63
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • QDEL's earnings are expected to grow with 23.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y25.08%
EPS Next 3Y23.97%

0

5. Dividend

5.1 Amount

  • QDEL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

QUIDELORTHO CORP

NASDAQ:QDEL (2/13/2026, 8:00:00 PM)

After market: 23.85 +0.27 (+1.15%)

23.58

-0.16 (-0.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners123.47%
Inst Owner Change-1.26%
Ins Owners0.61%
Ins Owner Change1.31%
Market Cap1.60B
Revenue(TTM)N/A
Net Income(TTM)-1.18B
Analysts74.29
Price Target38.18 (61.92%)
Short Float %15.76%
Short Ratio10.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)381.21%
Min EPS beat(2)70.71%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)197.7%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)123.74%
EPS beat(12)10
Avg EPS beat(12)89.01%
EPS beat(16)13
Avg EPS beat(16)77.39%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)8
Avg Revenue beat(12)2.03%
Revenue beat(16)11
Avg Revenue beat(16)2.72%
PT rev (1m)1.55%
PT rev (3m)-6.82%
EPS NQ rev (1m)-20.43%
EPS NQ rev (3m)-53.46%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)-6.44%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-2.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 11.12
Fwd PE 9.3
P/S 0.59
P/FCF N/A
P/OCF 42.94
P/B 0.79
P/tB N/A
EV/EBITDA 7.63
EPS(TTM)2.12
EY8.99%
EPS(NY)2.54
Fwd EY10.76%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)0.55
OCFY2.33%
SpS39.96
BVpS29.98
TBVpS-8.41
PEG (NY)0.57
PEG (5Y)N/A
Graham Number37.81
Profitability
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROCE 2.2%
ROIC 1.74%
ROICexc 1.78%
ROICexgc 3.88%
OM 3.98%
PM (TTM) N/A
GM 47.15%
FCFM N/A
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexgc growth 3Y-72.1%
ROICexgc growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA 4.57
Cap/Depr 43.31%
Cap/Sales 7%
Interest Coverage 250
Cash Conversion 6.82%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.98
Altman-Z 0.72
F-Score5
WACC9.67%
ROIC/WACC0.18
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
EPS Next Y19.63%
EPS Next 2Y25.08%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.23%
Revenue Next Year2.28%
Revenue Next 2Y3.23%
Revenue Next 3Y3.5%
Revenue Next 5YN/A
EBIT growth 1Y4.34%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year940.25%
EBIT Next 3Y132.92%
EBIT Next 5Y90.11%
FCF growth 1Y-203.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.9%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QDEL.


What is the valuation status for QDEL stock?

ChartMill assigns a valuation rating of 7 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Undervalued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 3 / 10.


What are the PE and PB ratios of QUIDELORTHO CORP (QDEL) stock?

The Price/Earnings (PE) ratio for QUIDELORTHO CORP (QDEL) is 11.12 and the Price/Book (PB) ratio is 0.79.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 19.63% in the next year.